IGF2BP1 and hepatocellular carcinoma: HCC progression and metastatic spread are inhibited through lncRNA LINC01093 specific to the liver, which also acts as protein scaffolding on the way to induce insulin-like growth factor mRNA binding protein1 (IGF2BP1) and to further promote the degradation of Glioma-associated oncogene homologue 1 (GLI1) mRNA [254].